GenMont Biotech, Inc.(TW:3164)
NT$16.75+0.10 (+0.60%)
TW:3164
GenMont Biotech, Inc. Revenue
NT$16.75
At close:+0.10 (+0.60%)
GenMont Biotech, Inc. (3164) Revenue
GenMont Biotech, Inc. Revenue
GenMont Biotech, Inc. had a revenue of 103.33M in the quarter ending Jun 30, 2026, with 15.88%. This bring the company's revenue in the last twelve months to 382.11M, Decreased 2.26%. In the fiscal year ending Dec 31, 2025, GenMont Biotech, Inc. had annual revenue of 401.23M with 4.11% growth.
- Revenue (ttm)
- 382.11M
- Revenue Growth
- 1.32%
- P/S Ratio
- 3.59
- Revenue/Employee
- TWD 2,729,449
- Employees
- 147
- Market Cap
- TWD 1.44B
Revenue Chart
GenMont Biotech, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 401.23M | 15.86M | 4.11% |
| Dec 31, 2024 | 385.37M | 67.36M | 21.18% |
| Dec 31, 2023 | 318.01M | -50.53M | -13.71% |
| Dec 31, 2022 | 368.55M | -59.38M | -13.88% |
| Dec 31, 2021 | 427.93M | 102.74M | 31.59% |
| Dec 31, 2020 | 325.19M | -21.05M | -6.08% |
| Dec 31, 2019 | 346.24M | -60.29M | -14.83% |
| Dec 31, 2018 | 406.53M | 25.88M | 6.80% |
| Dec 31, 2017 | 380.65M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.